• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SOX17-mediated immune evasion in early colorectal cancer: From pre-malignant adaptation to tumor progression.

作者信息

Gao Yanfeng, Wang Yanping, Zhao Jinsong, Song Yujun

机构信息

School of Medical Imaging, Wannan Medical College, Wuhu 241002, China.

College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing 210023, China.

出版信息

Acta Pharm Sin B. 2024 Aug;14(8):3780-3782. doi: 10.1016/j.apsb.2024.05.021. Epub 2024 May 31.

DOI:10.1016/j.apsb.2024.05.021
PMID:39220885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11365418/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/11365418/39633a6fb459/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/11365418/39633a6fb459/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/744b/11365418/39633a6fb459/gr1.jpg

相似文献

1
SOX17-mediated immune evasion in early colorectal cancer: From pre-malignant adaptation to tumor progression.SOX17介导的早期结直肠癌免疫逃逸：从癌前适应到肿瘤进展
Acta Pharm Sin B. 2024 Aug;14(8):3780-3782. doi: 10.1016/j.apsb.2024.05.021. Epub 2024 May 31.
2
SOX17 enables immune evasion of early colorectal adenomas and cancers.SOX17 能够使早期结直肠腺瘤和癌症逃避免疫。
Nature. 2024 Mar;627(8004):636-645. doi: 10.1038/s41586-024-07135-3. Epub 2024 Feb 28.
3
Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.靶向基于 CRISPR/Cas9 的基因组编辑工具的免疫系统细胞重编程创新策略：癌症管理的新时代。
Int J Nanomedicine. 2023 Sep 29;18:5531-5559. doi: 10.2147/IJN.S424872. eCollection 2023.
4
COPS6 promotes tumor progression and reduces CD8 T cell infiltration by repressing IL-6 production to facilitate tumor immune evasion in breast cancer.COPS6 通过抑制 IL-6 的产生促进肿瘤进展并减少 CD8 T 细胞浸润，从而促进乳腺癌的肿瘤免疫逃逸。
Acta Pharmacol Sin. 2023 Sep;44(9):1890-1905. doi: 10.1038/s41401-023-01085-8. Epub 2023 Apr 24.
5
Explorations of CRISPR/Cas9 for improving the long-term efficacy of universal CAR-T cells in tumor immunotherapy.CRISPR/Cas9 技术在提高通用 CAR-T 细胞肿瘤免疫治疗长期疗效中的探索。
Life Sci. 2023 Mar 1;316:121409. doi: 10.1016/j.lfs.2023.121409. Epub 2023 Jan 19.
6
CXCL8 induces M2 macrophage polarization and inhibits CD8 T cell infiltration to generate an immunosuppressive microenvironment in colorectal cancer.CXCL8 诱导 M2 巨噬细胞极化，并抑制 CD8 T 细胞浸润，从而在结直肠癌中产生免疫抑制微环境。
FASEB J. 2023 Oct;37(10):e23173. doi: 10.1096/fj.202201982RRR.
7
Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy.基因编辑 mRNA 纳米疗法抑制宫颈癌进展并调节过继性 T 细胞治疗的免疫抑制微环境。
J Control Release. 2023 Aug;360:496-513. doi: 10.1016/j.jconrel.2023.07.007. Epub 2023 Jul 12.
8
SOX17: escape route from immune destruction in early CRC.SOX17：早期 CRC 中免疫破坏的逃逸途径。
Trends Mol Med. 2024 Jul;30(7):609-611. doi: 10.1016/j.molmed.2024.04.001. Epub 2024 Apr 9.
9
Metabolic shift underlies tumor progression and immune evasion in S-nitrosoglutathione reductase-deficient cancer.代谢重编程是 S-亚硝基谷胱甘肽还原酶缺陷型癌症肿瘤进展和免疫逃逸的基础。
J Pathol. 2023 Jul;260(3):261-275. doi: 10.1002/path.6080. Epub 2023 Apr 5.
10
Reprogramming the Tumor Microenvironment through Second-Near-Infrared-Window Photothermal Genome Editing of PD-L1 Mediated by Supramolecular Gold Nanorods for Enhanced Cancer Immunotherapy.通过超分子金纳米棒介导的第二近红外窗口光热 PD-L1 基因编辑重编程肿瘤微环境用于增强癌症免疫治疗。
Adv Mater. 2021 Mar;33(12):e2006003. doi: 10.1002/adma.202006003. Epub 2021 Feb 4.

本文引用的文献

1
SOX17 enables immune evasion of early colorectal adenomas and cancers.SOX17 能够使早期结直肠腺瘤和癌症逃避免疫。
Nature. 2024 Mar;627(8004):636-645. doi: 10.1038/s41586-024-07135-3. Epub 2024 Feb 28.
2
Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy.逻辑门控肿瘤微环境纳米放大器实现CRISPR/Cas9的靶向递送用于多模态癌症治疗。
Acta Pharm Sin B. 2024 Feb;14(2):795-807. doi: 10.1016/j.apsb.2023.09.016. Epub 2023 Oct 1.
3
A Gene-Editable Palladium-Based Bioorthogonal Nanoplatform Facilitates Macrophage Phagocytosis for Tumor Therapy.
基于基因编辑的钯基生物正交纳米平台促进巨噬细胞吞噬用于肿瘤治疗。
Angew Chem Int Ed Engl. 2023 Dec 11;62(50):e202313968. doi: 10.1002/anie.202313968. Epub 2023 Nov 10.
4
An Enzyme-Loaded Metal-Organic Framework-Assisted Microfluidic Platform Enables Single-Cell Metabolite Analysis.载酶金属有机框架辅助微流控平台实现单细胞代谢物分析。
Angew Chem Int Ed Engl. 2023 Aug 1;62(31):e202302000. doi: 10.1002/anie.202302000. Epub 2023 May 23.
5
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.靶向纳米药物重塑免疫抑制性肿瘤微环境以增强癌症免疫治疗。
Acta Pharm Sin B. 2022 Dec;12(12):4327-4347. doi: 10.1016/j.apsb.2022.11.001. Epub 2022 Nov 4.
6
Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy.肿瘤微环境激活的双链基因组编辑纳米前药用于敏化近红外二氧化钛光疗。
Acta Pharm Sin B. 2022 Nov;12(11):4224-4234. doi: 10.1016/j.apsb.2022.06.016. Epub 2022 Jul 2.
7
Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment.靶向肿瘤内皮细胞的糖酵解通过重塑肿瘤微环境增强免疫治疗。
Acta Pharm Sin B. 2022 Apr;12(4):1825-1839. doi: 10.1016/j.apsb.2022.02.014. Epub 2022 Feb 22.
8
Hypoxia-Responsive Platinum Supernanoparticles for Urinary Microfluidic Monitoring of Tumors.缺氧响应性铂超纳米粒子用于肿瘤的尿液微流控监测。
Angew Chem Int Ed Engl. 2022 Mar 28;61(14):e202114239. doi: 10.1002/anie.202114239. Epub 2022 Feb 10.
9
Self-propelled nanomotor reconstructs tumor microenvironment through synergistic hypoxia alleviation and glycolysis inhibition for promoted anti-metastasis.自驱动纳米马达通过协同缓解缺氧和抑制糖酵解来重建肿瘤微环境，以促进抗转移。
Acta Pharm Sin B. 2021 Sep;11(9):2924-2936. doi: 10.1016/j.apsb.2021.04.006. Epub 2021 Apr 13.
10
Hypoxia-Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild-Photothermal Therapy.缺氧响应性基因编辑降低肿瘤热耐受以实现温和光热治疗。
Angew Chem Int Ed Engl. 2021 Sep 20;60(39):21200-21204. doi: 10.1002/anie.202107036. Epub 2021 Aug 17.